LeMaitre Vascular, Inc.

NASDAQ:LMAT

Medical - Instruments & Supplies

Healthcare
$75.58 +1.74%

+$1.60 today

Market cap
$1.73B
Beta
0.52
P/E (TTM)
34.3
EPS (TTM)
$2.74
Dividend yield
0.96%
52W Low $79.01High $118.01

Volume 0.22M

Average 0.26M

LMAT Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

LeMaitre Vascular, Inc.NASDAQ: LMAT

Gross Margin · Q1 FY2026 · quarter ended Mar 2026

Gross margin widens to 72.7%

Gross margin was 72.7% in Q1 FY2026, up 3.5 pp from a year earlier. On a trailing-twelve-month basis it was 72.4%, up 3.6 pp year over year. Over 3 fiscal years it widened by 6.6 pp.

Context

  • Gross margin widened in 3 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
72.7%+1.1 pp QoQ
Last fiscal yearDec 2025
71.5%+2.9 pp YoY
LTMMar 2026
72.4%+3.6 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+3.5 pp——
1 year+2.9 pp——
3 years+6.6 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
71.5%
Year-over-year change
+2.9pp

Gross Margin vs competitors

How LMAT compares with its peers on the latest reported figures

  • LMAT's LTM Mar 2026 gross margin of 72.4% is the highest of the 8 companies compared; the peer median is 62.9%.
  • Its year-over-year change of +3.6 pp is the 2nd highest of 8, against a peer median of +0.9 pp.
  • Over three fiscal years its change of +6.6 pp compares with a peer median of +1.5 pp.
LMAT Competitors Peer median
Gross Margin for LMAT and competitors
Company Period LTM level YoY 3-year change
LMATLeMaitre Vascular, Inc.LTM Mar 202672.4% +3.6 pp+6.6 pp
BSXBoston Scientific CorporationLTM Jun 202671.2% +7.9 pp+8.2 pp
PENPenumbra, Inc.LTM Jun 202667.8% +1.4 pp+4.0 pp
MDTMedtronic plcLTM Jul 202666.7% +3.3 pp-0.7 pp
AORTArtivion, Inc.LTM Mar 202662.9% -1.0 pp-3.3 pp
TFXTeleflex IncorporatedLTM Jun 202653.8% -1.8 pp+1.4 pp
ANGOAngioDynamics, Inc.LTM Feb 202653.5% -0.9 pp+1.5 pp
MMSIMerit Medical Systems, Inc.LTM Sep 202649.4% +0.9 pp+3.6 pp
Peer median (excluding LMAT) 62.9%+0.9 pp+1.5 pp

Competitors are the stored peer set for LMAT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue154.42M161.65M193.48M219.86M249.6M
Cost of Revenue53.04M56.76M66.44M68.96M71.06M
Gross Profit101.38M104.9M127.05M150.9M178.54M
Gross Margin65.7%64.9%65.7%68.6%71.5%
Research & Development11.8M13.29M16.97M15.65M14.14M
Selling, General & Admin53.16M61.67M72.89M83M96.49M
Operating Expenses64.96M78.07M90.34M98.65M110.63M
Depreciation & Amortization9.48M9.43M9.52M9.67M10.42M
EBITDA45.98M36.92M48.99M66.75M90.79M
EBITDA Margin29.8%22.8%25.3%30.4%36.4%
Operating Income36.43M26.83M36.71M52.26M67.91M
Operating Margin23.6%16.6%19.0%23.8%27.2%
Interest Income197K986K3.08M4.95M13.09M
Interest Expense2.22M00205K5.18M
Other Income / Expenses(2.14M)661K2.76M4.62M7.27M
Income Before Tax34.29M27.49M39.48M56.88M75.18M
Pre-Tax Margin22.2%17.0%20.4%25.9%30.1%
Income Tax Expense7.38M6.85M9.37M12.84M17.45M
Net Income26.91M20.64M30.11M44.04M57.73M
Net Margin17.4%12.8%15.6%20.0%23.1%
EPS (Basic)1.270.941.361.962.55
EPS (Diluted)1.250.931.341.932.52
Weighted Avg Shares21.16M21.98M22.22M22.45M22.64M
Weighted Avg Shares (Diluted)21.48M22.17M22.42M22.78M22.93M

LeMaitre Vascular, Inc.

NASDAQ:LMAT

Intrinsic Alpha fair value

Locked

Current Price

$75.58

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.